ABOUT

Biomark Capital is a venture capital and private equity firm comprised of experienced professionals with over 50 years of combined investment experience generating superior returns.

A confluence of events is changing healthcare globally and worldwide healthcare spending continues to grow at a rapid pace. Biomark Capital believes now is a compelling time to invest in game changing technologies that can broaden the foundation of healthcare practice, change the face of patient care, improve quality of life, and generate superior returns for our investors.

OUR FOCUS

Impact global healthcare by investing our capital and expertise on the most promising and best-in-class life science companies. Biomark Capital’s primary investment focus is in North America, along with a specific focus in Russia, Taiwan, India, and China. Our initial investments typically range from $5-$10 million dollars with key investment criteria including:

・       Highly Disruptive Innovation

・       Large Clinical Unmet Medical Need

・       Freedom-to-Operate / Large Barriers to Entry

・       Established Proof-of-Concept

・       Strong Management Team

OUR INVESTMENT STRATEGY

Partner with entrepreneurs to develop, establish, and build groundbreaking platform technologies into highly successful companies. We focus on innovation across the healthcare spectrum including:

・       Therapeutics and medical devices

・       Molecular diagnostics and healthcare delivery

・       Information technology